Triple therapy inhalers for COPD can reduce exacerbations but may increase pneumonia risk, necessitating careful patient phenotype assessment. Roflumilast and azithromycin effectively reduce COPD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback